Abstract:Jufei Wu, 1, &ast Jishi Wu, 2, &ast Yan Zhou, 3 Xiaohua Lu, 4 Wane Zhao, 4 Fengmei Xu 1 1 Department of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China; 2 Department of General Medicine, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China; 3 Department of Interventional Radiology & Vascular Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China; 4 Department of Endocrinology, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yan Zhou, Department of Interventional Radiology & Vascular Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China, Email Xiaohua Lu, Department of Endocrinology, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China, Email Purpose: To develop a prediction model for hypoglycemia in type 2 diabetes mellitus (T2DM) patients treated with an insulin pump during enteral nutrition. Methods: This retrospective study included T2DM patients treated with an insulin pump during enteral nutrition at the First Affiliated Hospital of Jinan University, Guangzhou Red Cross Hospital, Foshan First People's Hospital, and Guangdong Provincial Hospital of Traditional Chinese Medicine between January 2016 and December 2023. The patients were randomized 3:1 to the training and validation sets. The risk factors for hypoglycemia were analyzed. A prediction model was developed. Results: This study included 122 patients, and 57 patients had at least one hypoglycemic event during their hospitalization (46.72%). The multivariable logistic regression analysis showed that the time to reach the glycemic targets (odds ratio (OR)=1.408, 95% confidence interval (CI)=1.084– 1.825, P=0.006), average glycemia (OR=0.387, 95% CI=0.233– 0.643, P=0.010), coronary heart disease (OR=0.089, 95% CI=0.016– 0.497, P< 0.001), and the administration of hormone therapy (OR=6.807, 95% CI=1.128– 41.081, P=0.037) were independently associated with hypoglycemia. A nomogram was built. The receiver operating characteristics analysis showed that the area under the curve of the model was 0.872 (95% CI=0.0.803– 0.940) for the training set and 0.839 (95% CI=0.688– 0.991) in the validation set. Conclusion: A nomogram was successfully built to predict hypoglycemia in T2DM patients treated with an insulin pump during enteral nutrition, based on the time to reach the glycemic targets, average glycemia, coronary heart disease, and the administration of hormone therapy. Keywords: T2DM, hypoglycemia, enteral nutrition, insulin pump therapy, nomograms Diabetes mellitus is a prevalent chronic condition that results in significant disruptions in nutrient metabolism, giving rise to various severe complications. 1 For patients who are unable to consume nutrients orally but have a functioning gastrointestinal tract, enteral nutrition is the recommended method for providing nutritional support. 2 Enteral feeds are commonly prescribed for critically ill patients to provide nutritional support, and this approach is associated with improved mortality and morbidity outcomes. 3 However, it is important to note that the provision of carbohydrates in enteral feeds can lead to increased blood glucose excursion and variability. 3 Hyperglycemia is a common complication observed in hospitalized patients receiving enteral nutrition, and it affects approximately 21–30% of critically ill patients receiving this form of nutritional support. 4–6 The development of hyperglycemia during enteral nutrition is associated with elevated risks of death and infectious complications. 4 Among patients with diabetes, the presence of hyperglycemia may have negative effects on wound healing, prolong hospitalization, and increase the risk of complications (eg, diabetic ketoacidosis). 7 Therefore, it is important to achieve satisfactory glycemic control during enteral nutrition in patients with diabetes. Insulin therapy is the preferred regimen for glycemic control in all hospitalized hyperglycemic patients. 8 Insulin pump therapy provides flexible diabetic management and has gained popularity among patients with type 1 or 2 diabetes. 9 It allows for the customization of basal insulin delivery to meet the individual's daily insulin requirements and to accommodate variations in insulin needs throughout the day, including circadian patterns. 9 In -Abstract Truncated-

A Mathematical Model for Predicting Glucose Levels in Critically-Ill Patients: the PIGnOLI Model.

Predictive Value of Lactate in Unselected Critically Ill Patients: an Analysis Using Fractional Polynomials.

Incorporating real-world evidence into the development of patient blood glucose prediction algorithms for the ICU

A Mathematical Model to Estimate Mean Blood Glucose by Oral Glucose Tolerance Test

A Prediction Model of Gestational Diabetes Mellitus Based on OGTT in Early Pregnancy: A Prospective Cohort Study

Development and Validation of a Hypoglycemia Risk Model for Intensive Insulin Therapy in Patients with Type 2 Diabetes

A prediction model for assessing hypoglycemia risk in critically ill patients with sepsis

A Simple Modeling Framework For Prediction In The Human Glucose-Insulin System

A Glucose-Insulin Mixture Model and Application to Short-Term Hypoglycemia Prediction in the Night Time

The association between early blood glucose fluctuation and prognosis in critically ill patients]

A Stochastic Model-Based Control Methodology for Glycemic Management in the Intensive Care Unit

Model predictive control of blood glucose in critically ill patients using Gaussian processes

An OGI model for personalized estimation of glucose and insulin concentration in plasma

Impact of Intensive Insulin Therapy on Surgical Critically Ill Patients

Analysis of Glucose Responsive Glucagon Therapeutics using Computational Models of the Glucoregulatory System

Estimation of Glucose Absorption, Insulin Sensitivity, and Glucose Effectiveness From the Oral Glucose Tolerance Test

The Optimized Calculation Method for Insulin Dosage in an Insulin Tolerance Test (ITT): A Randomized Parallel Control Study.

The Optimized Calculation Method for Insulin Dosage in an Insulin Tolerance Test (ITT): A Randomized Parallel Control Study

[The Effect of Blood Glucose Fluctuations on Prognosis of Critically Ill Patients in Intensive Care Unit].

Analysis of the Islets-Based Glucose Control System Involving the Nonlinear Glucose-Insulin Metabolism Model

Nomogram for Predicting Hypoglycemia in Type 2 Diabetes Mellitus Patients Treated with Insulin Pump During Enteral Nutrition